Mouse FGF-basic (FGF-2/bFGF) Recombinant Protein, PeproTech and 1 more item

The University of Virginia awarded contract A207_PO-0446750-V3 to Life Technologies Corporation on July 11, 2026, for the procurement of recombinant protein products. The contract, valued at $589, encompasses two distinct line items: 289 units of Mouse Fibroblast Growth Factor-basic (FGF-2/bFGF) Recombinant Protein and 300 units of Mouse Platelet-Derived Growth Factor-AA (PDGF-AA) Recombinant Protein, both supplied by PeproTech. Each unit is priced at $1, with delivery to the University of Virginia.

This purchase order reflects the University of Virginia's acquisition of specialized laboratory reagents for research applications. Both products represent recombinant protein materials commonly utilized in cell biology and developmental research. As a state contract award in Virginia, this transaction falls under the University of Virginia's procurement authority. The contract documentation does not specify an explicit contract performance period; however, the award date of July 11, 2026, marks the formal contract execution.